C. Picard, W. Herz, A. Bousfiha, J. Casanova, T. Chatila et al., Primary Immunodeficiency Diseases: an Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency 2015, Journal of Clinical Immunology, vol.35, issue.8, pp.696-726, 2015.
DOI : 10.1007/s10875-015-0201-1

M. Eibl and H. Wolf, Vaccination in patients with primary immune deficiency, secondary immune deficiency and autoimmunity with immune regulatory abnormalities, Immunotherapy, vol.7, issue.12, pp.1273-92, 2015.
DOI : 10.2217/IMT.15.74

J. Guo, S. Bolivar-wagers, N. Srinivas, M. Holubar, and Y. Maldonado, Immunodeficiency-related vaccine-derived poliovirus (iVDPV) cases: A systematic review and implications for polio eradication, Vaccine, vol.33, issue.10, pp.1235-1277, 2015.
DOI : 10.1016/j.vaccine.2015.01.018

M. Shaghaghi, S. Shahmahmoodi, H. Abolhassani, S. Soleyman-jahi, L. Parvaneh et al., Vaccine-derived polioviruses and children with primary immunodeficiency, Emerg Infect Dis, vol.22, issue.10, pp.1995-20141712, 2016.
DOI : 10.3201/eid2210.151071
URL : http://doi.org/10.3201/eid2210.151071

H. Abolhassani, M. Vitali, V. Lougaris, S. Giliani, N. Parvaneh et al., Cohort of Iranian Patients with Congenital Agammaglobulinemia: Mutation Analysis and Novel Gene Defects, Expert Review of Clinical Immunology, vol.58, issue.3, pp.479-86, 2016.
DOI : 10.1111/j.0105-2896.2005.00233.x

O. Diop, C. Burns, R. Sutter, S. Wassilak, and O. Kew, Centers for Disease Control and Prevention (CDC) Update on vaccine-derived polioviruses ? worldwide, MMWR Morb Mortal Wkly Rep, issue.23, pp.64640-64646, 2014.

O. Kew, R. Sutter, E. De-gourville, W. Dowdle, and M. Pallansch, VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION, Annual Review of Microbiology, vol.59, issue.1, pp.587-635, 2005.
DOI : 10.1146/annurev.micro.58.030603.123625

R. Trimble, J. Atkins, T. Quigg, C. Burns, G. Wallace et al., Vaccine-associated paralytic poliomyelitis and BCG-osis in an immigrant child with severe combined immunodeficiency syndrome ? Texas, MMWR Morb Mortal Wkly Rep, issue.33, pp.63721-63725, 2013.

M. Morales, R. Tangermann, and S. Wassilak, Progress toward polio eradication ? worldwide, MMWR Morb Mortal Wkly Rep, vol.65, issue.18, pp.2015-2016470, 2016.
DOI : 10.15585/mmwr.mm6518a4

N. Driss, I. Ben-mustapha, F. Mellouli, B. Yahia, A. Touzi et al., High Susceptibility for Enterovirus Infection and Virus Excretion Features in Tunisian Patients with Primary Immunodeficiencies, Clinical and Vaccine Immunology, vol.19, issue.10, pp.1684-1693, 2012.
DOI : 10.1128/CVI.00293-12
URL : https://hal.archives-ouvertes.fr/pasteur-00859422

M. Conley, L. Notarangelo, and A. Etzioni, Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID
DOI : 10.1006/clim.1999.4799

F. Bonilla, I. Bernstein, D. Khan, Z. Ballas, J. Chinen et al., Practice parameter for the diagnosis and management of primary immunodeficiency, Journal of Allergy and Clinical Immunology, vol.136, issue.5, pp.1-63, 2005.
DOI : 10.1016/j.jaci.2015.04.049

N. Driss, F. Mellouli, B. Yahia, A. Touzi, H. Barbouche et al., Sequential Asymptomatic Enterovirus Infections in a Patient with Major Histocompatibility Complex Class II Primary Immunodeficiency: FIG 1, Journal of Clinical Microbiology, vol.52, issue.9, pp.3486-3495, 2014.
DOI : 10.1128/JCM.01122-14

H. Sazzad, J. Rainey, A. Kahn, O. Mach, J. Liyanage et al., Screening for Long-term Poliovirus Excretion Among Children With Primary Immunodeficiency Disorders: Preparation for the Polio Posteradication Era in Bangladesh, Journal of Infectious Diseases, vol.210, issue.suppl 1, pp.373-382, 2014.
DOI : 10.1093/infdis/jiu221

R. De-silva, S. Gunasena, D. Ratnayake, G. Wickremesinghe, C. Kumarasiri et al., Prevalence of prolonged and chronic poliovirus excretion among persons with primary immune deficiency disorders in Sri Lanka, Vaccine, vol.30, issue.52, pp.7561-7566, 2012.
DOI : 10.1016/j.vaccine.2012.10.035

N. Halsey, J. Pinto, F. Espinosa-rosales, M. Faure-fontenla, E. Da-silva et al., Search for poliovirus carriers among people with primary immune deficiency diseases in the United States, Mexico, Brazil, and the United Kingdom, Bull World Health Organ, vol.82, issue.1, pp.3-8, 2004.

Z. El-sayed, O. Mach, E. Hossny, N. Galal, I. El-sawy et al., Poliovirus excretion among persons with primary immune deficiency disorders: summary of data from enhanced poliovirus surveillance in Egypt, J Vaccines Vaccin, vol.7, issue.4, pp.2011-2014331, 2016.

V. Modell, J. Quinn, J. Orange, L. Notarangelo, and F. Modell, Primary immunodeficiencies worldwide: an updated overview from the Jeffrey Modell Centers Global Network, Immunologic Research, vol.21, issue.2, pp.736-53, 2016.
DOI : 10.1016/j.bbmt.2014.11.352

A. Chetverin, The puzzle of RNA recombination, FEBS Letters, vol.19, issue.1, pp.1-5, 1999.
DOI : 10.1093/nar/19.7.1605

S. Guillot, V. Caro, N. Cuervo, E. Korotkova, M. Combiescu et al., Natural Genetic Exchanges between Vaccine and Wild Poliovirus Strains in Humans, Journal of Virology, vol.74, issue.18, pp.8434-8477, 2000.
DOI : 10.1128/JVI.74.18.8434-8443.2000
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC116354/pdf

A. Georgopoulou and P. Markoulatos, Sabin Type 2 Polioviruses with Intertypic Vaccine/Vaccine Recombinant Genomes, European Journal of Clinical Microbiology & Infectious Diseases, vol.20, issue.11, pp.792-801, 2001.
DOI : 10.1007/s100960100610

I. Karakasiliotis, P. Markoulatos, and T. Katsorchis, Site analysis of recombinant and mutant poliovirus isolates of Sabin origin from patients and from vaccinees, Molecular and Cellular Probes, vol.18, issue.2, 2004.
DOI : 10.1016/j.mcp.2003.09.009

R. Puligedda, D. Kouiavskaia, S. Adekar, R. Sharma, D. Kattala et al., Human monoclonal antibodies that neutralize vaccine and wild-type poliovirus strains, Antiviral Research, vol.108, pp.36-43, 2014.
DOI : 10.1016/j.antiviral.2014.05.005

Y. He, S. Mueller, P. Chipman, C. Bator, X. Peng et al., Complexes of Poliovirus Serotypes with Their Common Cellular Receptor, CD155, Journal of Virology, vol.77, issue.8, pp.4827-4862, 2003.
DOI : 10.1128/JVI.77.8.4827-4835.2003

D. Tebbens, R. Thompson, and K. , SUMMARY, Epidemiology and Infection, vol.145, issue.02, pp.217-243, 2017.
DOI : 10.1017/S0950268816002302

R. Wahid, M. Cannon, and M. Chow, Virus-Specific CD4+ and CD8+ Cytotoxic T-Cell Responses and Long-Term T-Cell Memory in Individuals Vaccinated against Polio, Journal of Virology, vol.79, issue.10, pp.5988-95, 2005.
DOI : 10.1128/JVI.79.10.5988-5995.2005
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1091702

M. Mckinlay, M. Collett, J. Hincks, M. Oberste, M. Pallansch et al., Progress in the Development of Poliovirus Antiviral Agents and Their Essential Role in Reducing Risks That Threaten Eradication, Journal of Infectious Diseases, vol.210, issue.suppl 1, pp.447-53, 2014.
DOI : 10.1093/infdis/jiu043

S. Dehkordy, A. Aghamohammadi, H. Ochs, and N. Rezaei, Primary Immunodeficiency Diseases Associated with Neurologic Manifestations, Journal of Clinical Immunology, vol.16, issue.9596, pp.1-24, 2012.
DOI : 10.3201/eid1606.091536

D. Palma, A. Pürstinger, G. Wimmer, E. Patick, A. Andries et al., Potential Use of Antiviral Agents in Polio Eradication, Emerging Infectious Diseases, vol.14, issue.4, pp.545-51, 2008.
DOI : 10.3201/eid1404.070439